| Literature DB >> 27234404 |
Hang Yang1, Mingyao Luo2, Qianlong Chen1, Yuanyuan Fu1, Jing Zhang2, Xiangyang Qian2, Xiaogang Sun2, Yuxin Fan3, Zhou Zhou4, Qian Chang5.
Abstract
Marfan syndrome (MFS) is an autosomal dominant connective tissue disorder typically involving the ocular, skeletal and cardiovascular systems, and aortic aneurysms/dissection mainly contributes to its mortality. Here, we performed genetic testing of the FBN1 gene in 39 Chinese probands with Marfan/Marfan-like syndrome and their related family members by Sanger sequencing. In total, 29 pathogenic/likely pathogenic FBN1 mutations, including 17 novel ones, were identified. In addition, most MFS patients with aortic disease (62%) had a truncating or splicing mutation. These results expand the FBN1 mutation spectrum and enrich our knowledge of genotype-phenotype correlations. Genetic testing for MFS and its related aortic diseases is increasingly important for early intervention and treatment.Entities:
Keywords: Aortic disease; FBN1 gene; Genetic testing; Marfan syndrome
Mesh:
Substances:
Year: 2016 PMID: 27234404 DOI: 10.1016/j.cca.2016.05.021
Source DB: PubMed Journal: Clin Chim Acta ISSN: 0009-8981 Impact factor: 3.786